Sofen相关文献与解析，生知库 | 链接生命科学的每一步

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis

Deucravacitinib治疗对Apremilast疗效不佳的斑块状银屑病：POETYK III期分析

Armstrong, April W; Warren, Richard B; Sofen, Howard; Spelman, Lynda; Linaberry, Misti; Becker, Brandon; Jou, Ying-Ming; Daamen, Carolin; Kimball, Alexa B

银屑病

发表日期：2026

文献求助收藏

Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials

Deucravacitinib治疗中重度斑块状银屑病长达3年的安全性和有效性：一项随机临床试验的开放标签扩展研究

期刊:Jama Dermatology

影响因子:11

doi:10.1001/jamadermatol.2024.4688

Armstrong, April W; Lebwohl, Mark; Warren, Richard B; Sofen, Howard; Imafuku, Shinichi; Ohtsuki, Mamitaro; Spelman, Lynda; Passeron, Thierry; Papp, Kim A; Kisa, Renata M; Vaile, John; Berger, Victoria; Vritzali, Eleni; Hoyt, Kim; Colombo, Matthew J; Scotto, Julie; Banerjee, Subhashis; Strober, Bruce; Thaçi, Diamant; Blauvelt, Andrew

银屑病

发表日期：2025

文献求助收藏

Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial

Nemolizumab治疗中重度结节性痒疹患者的疗效和安全性：OLYMPIA 1随机临床3期试验

期刊:Jama Dermatology

影响因子:11

doi:10.1001/jamadermatol.2024.4796

Ständer, Sonja; Yosipovitch, Gil; Legat, Franz J; Reich, Adam; Paul, Carle; Simon, Dagmar; Naldi, Luigi; Metz, Martin; Tsianakas, Athanasios; Pink, Andrew; Fage, Simon; Micali, Giuseppe; Weisshaar, Elke; Sundaram, Hema; Metelitsa, Andrei; Augustin, Matthias; Wollenberg, Andreas; Homey, Bernhard; Fargnoli, Maria Concetta; Sofen, Howard; Korman, Neil J; Skov, Lone; Chen, Xiaoxiao; Jabbar-Lopez, Zarif K; Piketty, Christophe; Kwatra, Shawn G

MPI

发表日期：2025

文献求助收藏

Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials

Deucravacitinib治疗斑块状银屑病：POETYK PSO-1、PSO-2 和长期扩展试验的3期安全性和有效性结果

期刊:Journal of the European Academy of Dermatology and Venereology

影响因子:8

doi:10.1111/jdv.20553

Armstrong, April W; Lebwohl, Mark; Warren, Richard B; Sofen, Howard; Morita, Akimichi; Paul, Carle; Papp, Kim A; Colombo, Matthew J; Scotto, Julie; Vaile, John; Zhuo, Joe; Vritzali, Eleni; Berger, Victoria; Schroeder, Georgene; Banerjee, Subhashis; Thaçi, Diamant; Strober, Bruce

银屑病

发表日期：2025

文献求助收藏

Daily microbial rhythms of the surface ocean interrupted by the new moon-a lipidomic study

新月扰乱表层海洋微生物的昼夜节律——一项脂质组学研究

期刊:ISME Communications

影响因子:6.1

doi:10.1093/ismeco/ycaf044

Hwang, Jiwoon; Hayward, Alexander; Sofen, Laura E; Pitz, Kathleen J; Chavez, Francisco P; Edwards, Bethanie R

微生物学

发表日期：2025

文献求助收藏

Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials

Deucravacitinib：3期斑块状银屑病试验中值得关注的不良事件

期刊:Dermatology and Therapy

影响因子:4.2

doi:10.1007/s13555-025-01337-x

Merola, Joseph F; Ferris, Laura K; Sobell, Jeffrey M; Sofen, Howard; Osborne, John; Vaile, John; Jou, Ying-Ming; Daamen, Carolin; Scotto, Julie; Scharnitz, Thomas; Lebwohl, Mark

银屑病

发表日期：2025

文献求助收藏

Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children

两项针对成人和儿童的3期特应性皮炎试验表明，他那洛夫可改善患者及其家人的预后和睡眠质量

期刊:Dermatology and Therapy

影响因子:4.2

doi:10.1007/s13555-024-01318-6

Simpson, Eric L; Hebert, Adelaide A; Browning, John; Serrao, Rocco T; Sofen, Howard; Brown, Philip M; Piscitelli, Stephen C; Rubenstein, David S; Tallman, Anna M

发表日期：2025

文献求助收藏

Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis

Lebrikizumab 可改善中重度特应性皮炎患者的生活质量以及患者自述的焦虑和抑郁症状

期刊:Dermatology and Therapy

影响因子:4.2

doi:10.1007/s13555-024-01199-9

Lio, Peter A; Armstrong, April; Gutermuth, Jan; Nosbaum, Audrey; Sofen, Howard; Gil, Esther Garcia; Casillas, Marta; Chen, Sherry; Sun, Luna; Pierce, Evangeline; Elmaraghy, Hany; Dawson, Zach; Torres, Tiago

Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years

鲁索替尼乳膏治疗白癜风的安全性和有效性：一项随机对照试验的3年二次分析

期刊:Skin Health and Disease

影响因子:

doi:10.1002/ski2.404

Harris, John E; Pandya, Amit G; Lebwohl, Mark; Hamzavi, Iltefat H; Grimes, Pearl; Gottlieb, Alice B; Sofen, Howard L; Moore, Angela Y; Wang, Mingyue; Kornacki, Deanna; Butler, Kathleen; Rosmarin, David

发表日期：2024

文献求助收藏

Vixarelimab in Patients With Prurigo Nodularis: A Randomized Clinical Trial

Vixarelimab治疗结节性痒疹患者：一项随机临床试验

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis

Deucravacitinib治疗对Apremilast疗效不佳的斑块状银屑病：POETYK III期分析

Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials

Deucravacitinib治疗中重度斑块状银屑病长达3年的安全性和有效性：一项随机临床试验的开放标签扩展研究

Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial

Nemolizumab治疗中重度结节性痒疹患者的疗效和安全性：OLYMPIA 1随机临床3期试验

Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials

Deucravacitinib治疗斑块状银屑病：POETYK PSO-1、PSO-2 和长期扩展试验的3期安全性和有效性结果

Daily microbial rhythms of the surface ocean interrupted by the new moon-a lipidomic study

新月扰乱表层海洋微生物的昼夜节律——一项脂质组学研究

Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials

Deucravacitinib：3期斑块状银屑病试验中值得关注的不良事件

Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children

两项针对成人和儿童的3期特应性皮炎试验表明，他那洛夫可改善患者及其家人的预后和睡眠质量

Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis

Lebrikizumab 可改善中重度特应性皮炎患者的生活质量以及患者自述的焦虑和抑郁症状

Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years

鲁索替尼乳膏治疗白癜风的安全性和有效性：一项随机对照试验的3年二次分析